TSX News -
Theratechnologies Acquires Commercial Rights to Ibalizumab in the European Union and Four Additional Territories
MONTREAL, QUEBEC–(Marketwired – March 6, 2017) – Theratechnologies Inc. (Theratechnologies) (TSX:TH) is pleased to announce that it has reached an […]